Business News • MarketWire • Radient Pharmaceuticals Onko-Sure(R) In Vitro Diagnostic Cancer Test Potentially Effective as Veterinary Cancer Tumor Marker

Radient Pharmaceuticals Onko-Sure(R) In Vitro Diagnostic Cancer Test Potentially Effective as Veterinary Cancer Tumor Marker

Radient Pharmaceuticals Onko-Sure(R) In Vitro Diagnostic Cancer Test Potentially Effective as Veterinary Cancer Tumor Marker

TUSTIN, CA--(Marketwire - December 8, 2010) - Radient Pharmaceuticals Corporation (RPC) (NYSE Amex: RPC) today announced it has completed a pilot clinical study to measure the feasibility of using its Onko-Sure® in vitro diagnostic (IVD) cancer test kit as a veterinary tumor marker initially for cancer detection in domestic cats.

View More : http://www.marketwire.com/mw/release.do?id=1365771&sourceType=3

Releted News by marketwire

Silver Shines Bright as Bernanke Stirs Up Controversy

Significant Growth Prospects Present in Memory Chip Market